Clinical Trials in Localized Muscle-Invasive Bladder Cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Recent advances in surgical techniques, bladder cancer molecular biology discoveries, access to point-of-care genomic biomarker platforms, and therapy options in metastatic bladder cancer patients suggest that significant improvements in the options and outcomes for patients with muscle-invasive bladder cancer (MIBC) are achievable. Indeed, multiple MIBC clinical trials with practice-changing impact are ongoing. This chapter provides a synopsis of the key populations, designs, and endpoints under investigation in these important MIBC trials.

Original languageEnglish (US)
Title of host publicationBladder Cancer
Subtitle of host publicationA Practical Guide
PublisherSpringer International Publishing
Pages355-363
Number of pages9
ISBN (Electronic)9781484271070
ISBN (Print)9781484271063
DOIs
StatePublished - Jan 1 2021

Keywords

  • Bladder cancer
  • Clinical trials
  • Muscle-invasive
  • Phase 2
  • Phase 3
  • Urothelial cancer

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Clinical Trials in Localized Muscle-Invasive Bladder Cancer'. Together they form a unique fingerprint.

Cite this